Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
BFB
First Extension - Granted
Show more
Class 5: Antibodies for medical purposes; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of cancer, oncologic diseases and disorders, inflammation and immunity diseases and disorders, immunodeficiency diseases and disorders, genetic diseases and disorders, metabolic diseases and disorders, neurodegenerative diseases and disorders, kidney diseases and disorders, eye diseases and disorders, uveitis, glomerulosclerosis, glomerulonephritis, cardiovascu…
Class 42: Pharmaceutical research and development; Research and development services in the field of antibodies; Providing medical and scientific research information; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmacogenetics; Research and development in the field of biologics, namely, antibodies and peptides for the field of cancer, immunology and inflammation diseases, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, uveitis, glomerulosclerosis, glomerulonephritis, and cardiovascular dise…
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 4 Jun 2025Application filedNew Application Entered
- 24 Oct 2025Assigned to an examining attorneyAssigned To Examiner
- 24 Oct 2025Approved for publicationApproved For Pub - Principal Register
- 25 Nov 2025Published for oppositionPublished For Opposition
- 20 Jan 2026Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 21 Jul 2026Statement-of-use extension 1 grantedSou Extension 1 Granted
All 13 events
| 2026-07-21 | Sou Extension 1 Granted |
| 2026-07-21 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-07-20 | Sou Teas Extension Received |
| 2026-07-20 | Sou Extension 1 Filed |
| 2026-01-20 | Noa Mailed - Sou Required From Applicant |
| 2025-11-25 | Published For Opposition |
| 2025-11-25 | Official Gazette Publication Confirmation E-Mailed |
| 2025-11-19 | Notification Of Notice Of Publication E-Mailed |
| 2025-10-24 | Assigned To Examiner |
| 2025-10-24 | Approved For Pub - Principal Register |
| 2025-10-10 | New Application Office Supplied Data Entered |
| 2025-06-04 | New Application Entered |
| 2025-06-04 | Application Filing Receipt Mailed |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Antibodies for medical purposes; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of cancer, oncologic diseases and disorders, inflammation and immunity diseases and disorders, immunodeficiency diseases and disorders, genetic diseases and disorders, metabolic diseases and disorders, neurodegenerative diseases and disorders, kidney diseases and disorders, eye diseases and disorders, uveitis, glomerulosclerosis, glomerulonephritis, cardiovascu…
Class 42 Technology & SaaS
Pharmaceutical research and development; Research and development services in the field of antibodies; Providing medical and scientific research information; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmacogenetics; Research and development in the field of biologics, namely, antibodies and peptides for the field of cancer, immunology and inflammation diseases, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, uveitis, glomerulosclerosis, glomerulonephritis, and cardiovascular dise…
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 21 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.